DK3919060T3 - Ecopipam til behandling af Tourettes syndrom - Google Patents

Ecopipam til behandling af Tourettes syndrom

Info

Publication number: DK3919060T3
Authority: DK; Denmark
Prior art keywords: ecopipam; treatment; tourette syndrome; tourette; syndrome
Prior art date: 2012-07-12

Application number

DK21170063.8T

Other languages

English (en)

Inventor

Richard E Chipkin

Rudolf Kwan

Original Assignee

Emalex Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-07-12

Filing date

2013-07-12

Publication date

2025-09-15

2013-07-12 Application filed by Emalex Biosciences Inc filed Critical Emalex Biosciences Inc

2025-09-15 Application granted granted Critical

2025-09-15 Publication of DK3919060T3 publication Critical patent/DK3919060T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK21170063.8T 2012-07-12 2013-07-12 Ecopipam til behandling af Tourettes syndrom DK3919060T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261671044P	2012-07-12	2012-07-12
EP13815988.4A EP2872145B8 (en)	2012-07-12	2013-07-12	Fused benzazepines for treatment of tourette's syndrome

Publications (1)

Publication Number	Publication Date
DK3919060T3 true DK3919060T3 (da)	2025-09-15

Family

ID=49916578

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK13815988.4T DK2872145T3 (da)	2012-07-12	2013-07-12	Kondenserede benzazepiner til behandling af tourettes syndrom
DK21170063.8T DK3919060T3 (da)	2012-07-12	2013-07-12	Ecopipam til behandling af Tourettes syndrom

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK13815988.4T DK2872145T3 (da)	2012-07-12	2013-07-12	Kondenserede benzazepiner til behandling af tourettes syndrom

Country Status (21)

Country	Link
US (2)	US11298361B2 (da)
EP (3)	EP2872145B8 (da)
JP (1)	JP6181754B2 (da)
KR (1)	KR20150029713A (da)
CN (1)	CN104540510A (da)
AU (1)	AU2013289922B2 (da)
CA (1)	CA2879020C (da)
CY (1)	CY1125221T1 (da)
DK (2)	DK2872145T3 (da)
ES (2)	ES2914043T3 (da)
FI (1)	FI3919060T3 (da)
HR (2)	HRP20251123T1 (da)
HU (2)	HUE072922T2 (da)
IL (4)	IL300144A (da)
LT (2)	LT3919060T (da)
PL (2)	PL2872145T3 (da)
PT (2)	PT2872145T (da)
RS (2)	RS63266B1 (da)
SI (2)	SI3919060T1 (da)
SM (2)	SMT202200234T1 (da)
WO (1)	WO2014012034A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9949983B2 (en)	2013-10-18	2018-04-24	Psyadon Pharmaceuticals, Inc.	Fused benzazepines for treatment of stuttering
AU2019345312A1 (en)	2018-09-20	2021-03-25	Ovid Therapeutics Inc.	Use of gaboxadol for the treatment of tourette syndrome, tics and stuttering
MX2022015400A (es) *	2020-06-05	2023-03-16	Noema Pharma Ag	Uso del inhibidor de la fosfodiesterasa a 10 para el tratamiento del sindrome de tourette.
WO2025194153A1 (en)	2024-03-15	2025-09-18	Emalex Biosciences, Inc.	Pharmaceutical dosage forms and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4477378A (en)	1980-02-05	1984-10-16	Schering Corp.	Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US5302716A (en)	1986-01-16	1994-04-12	Schering Corporation	Fused benzazepines
US4973586A (en)	1986-01-16	1990-11-27	Schering Corporation	Fused benzazepines, compositions of, and medical use thereof
BE1005064A4 (nl)	1991-07-03	1993-04-06	Asm Fico Tooling	Buiginrichting.
GB9127306D0 (en)	1991-12-23	1992-02-19	Boots Co Plc	Therapeutic agents
DK0750616T3 (da)	1994-03-16	2001-07-23	Cenes Ltd	Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
US5607967A (en)	1994-10-27	1997-03-04	Merck & Co., Inc.	Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
BR9814830A (pt)	1997-10-28	2000-10-03	Schering Corp	Método de redução de desejo em mamìferos
EP1058551A1 (en) *	1998-03-02	2000-12-13	Schering Corporation	Use of d1/d5 antagonists for treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism
US6132724A (en)	1998-04-29	2000-10-17	City Of Hope National Medical Center	Allelic polygene diagnosis of reward deficiency syndrome and treatment
SE9904724D0 (sv)	1999-12-22	1999-12-22	Carlsson A Research Ab	New modulators of dopamine neurotransmission I
WO2003039468A2 (en)	2001-11-06	2003-05-15	Haracz John L	Antimnemonic therapy for hypermemory syndromes
US8518933B2 (en)	2009-04-23	2013-08-27	Abbvie Inc.	Modulators of 5-HT receptors and methods of use thereof
WO2011057199A1 (en) *	2009-11-06	2011-05-12	Adenios, Inc.	Compositions for treating cns disorders
US20110206782A1 (en)	2010-02-24	2011-08-25	Auspex Pharmaceuticals, Inc.	Piperidine modulators of dopamine receptor
WO2012033874A1 (en) *	2010-09-10	2012-03-15	Chipkin Richard E	Method of treating compulsive self-injurious behaviors
US9949983B2 (en)	2013-10-18	2018-04-24	Psyadon Pharmaceuticals, Inc.	Fused benzazepines for treatment of stuttering

2013
- 2013-07-12 HR HRP20251123TT patent/HRP20251123T1/hr unknown
- 2013-07-12 KR KR1020157001403A patent/KR20150029713A/ko not_active Ceased
- 2013-07-12 IL IL300144A patent/IL300144A/en unknown
- 2013-07-12 EP EP13815988.4A patent/EP2872145B8/en active Active
- 2013-07-12 CN CN201380036903.9A patent/CN104540510A/zh active Pending
- 2013-07-12 EP EP25178813.9A patent/EP4616915A3/en active Pending
- 2013-07-12 RS RS20220519A patent/RS63266B1/sr unknown
- 2013-07-12 PL PL13815988T patent/PL2872145T3/pl unknown
- 2013-07-12 SI SI201332110T patent/SI3919060T1/sl unknown
- 2013-07-12 LT LTEP21170063.8T patent/LT3919060T/lt unknown
- 2013-07-12 RS RS20250912A patent/RS67203B1/sr unknown
- 2013-07-12 US US14/414,368 patent/US11298361B2/en active Active
- 2013-07-12 DK DK13815988.4T patent/DK2872145T3/da active
- 2013-07-12 DK DK21170063.8T patent/DK3919060T3/da active
- 2013-07-12 SM SM20220234T patent/SMT202200234T1/it unknown
- 2013-07-12 HU HUE21170063A patent/HUE072922T2/hu unknown
- 2013-07-12 ES ES13815988T patent/ES2914043T3/es active Active
- 2013-07-12 FI FIEP21170063.8T patent/FI3919060T3/fi active
- 2013-07-12 HU HUE13815988A patent/HUE058696T2/hu unknown
- 2013-07-12 AU AU2013289922A patent/AU2013289922B2/en active Active
- 2013-07-12 PL PL21170063.8T patent/PL3919060T3/pl unknown
- 2013-07-12 SI SI201331993T patent/SI2872145T1/sl unknown
- 2013-07-12 LT LTEPPCT/US2013/050337T patent/LT2872145T/lt unknown
- 2013-07-12 EP EP21170063.8A patent/EP3919060B1/en active Active
- 2013-07-12 ES ES21170063T patent/ES3041320T3/es active Active
- 2013-07-12 JP JP2015521856A patent/JP6181754B2/ja active Active
- 2013-07-12 PT PT138159884T patent/PT2872145T/pt unknown
- 2013-07-12 PT PT211700638T patent/PT3919060T/pt unknown
- 2013-07-12 HR HRP20220701TT patent/HRP20220701T1/hr unknown
- 2013-07-12 SM SM20250353T patent/SMT202500353T1/it unknown
- 2013-07-12 IL IL292725A patent/IL292725A/en unknown
- 2013-07-12 WO PCT/US2013/050337 patent/WO2014012034A1/en not_active Ceased
- 2013-07-12 CA CA2879020A patent/CA2879020C/en active Active
2014
- 2014-12-23 IL IL236403A patent/IL236403A0/en unknown
2021
- 2021-05-21 US US17/327,465 patent/US20210275540A1/en not_active Abandoned
- 2021-07-05 IL IL284615A patent/IL284615A/en unknown
2022
- 2022-05-31 CY CY20221100373T patent/CY1125221T1/el unknown

Also Published As

Publication number	Publication date
PL2872145T3 (pl)	2022-06-20
EP4616915A3 (en)	2025-12-17
LT2872145T (lt)	2022-06-27
SI2872145T1 (sl)	2022-07-29
EP2872145B8 (en)	2022-04-13
JP2015522082A (ja)	2015-08-03
HRP20220701T1 (hr)	2022-07-08
CY1125221T1 (el)	2025-03-28
SMT202200234T1 (it)	2022-07-21
CA2879020A1 (en)	2014-01-16
US20210275540A1 (en)	2021-09-09
HUE058696T2 (hu)	2022-09-28
AU2013289922B2 (en)	2016-12-15
RS67203B1 (sr)	2025-10-31
ES2914043T3 (es)	2022-06-07
HRP20251123T1 (hr)	2025-11-21
WO2014012034A1 (en)	2014-01-16
DK2872145T3 (da)	2022-06-13
SMT202500353T1 (it)	2025-11-10
US20150164911A1 (en)	2015-06-18
RS63266B1 (sr)	2022-06-30
US11298361B2 (en)	2022-04-12
PT3919060T (pt)	2025-09-25
IL284615A (en)	2021-08-31
EP3919060A1 (en)	2021-12-08
HUE072922T2 (hu)	2025-12-28
KR20150029713A (ko)	2015-03-18
ES3041320T3 (en)	2025-11-11
CA2879020C (en)	2021-02-09
HK1209336A1 (zh)	2016-04-01
EP3919060B1 (en)	2025-06-18
EP4616915A2 (en)	2025-09-17
IL236403A0 (en)	2015-02-26
CN104540510A (zh)	2015-04-22
EP2872145A4 (en)	2015-12-02
EP2872145B1 (en)	2022-03-09
IL300144A (en)	2023-03-01
PL3919060T3 (pl)	2025-10-20
AU2013289922A1 (en)	2015-01-29
EP2872145A1 (en)	2015-05-20
JP6181754B2 (ja)	2017-08-16
SI3919060T1 (sl)	2025-11-28
FI3919060T3 (fi)	2025-09-15
LT3919060T (lt)	2025-10-10
PT2872145T (pt)	2022-05-26
IL292725A (en)	2022-07-01

Publication	Publication Date	Title
DK3520805T3 (da)	2021-04-19	Sammensætninger til behandling af myelofibrose
EP3275481C0 (en)	2025-03-26	AUTO-INJECTOR
DK3354728T3 (da)	2020-07-27	Alpha-amylase-varianter
DK2906698T3 (da)	2019-11-04	Fremgangsmåde til behandling af alports syndrom
DK4389885T3 (da)	2025-11-17	Alfa-amylasevarianter
DK2861240T3 (da)	2020-09-28	Nukleinsyrer til behandling af allergier
EP2857440A4 (en)	2016-03-09	Hard coating film
BR112014013850A2 (pt)	2017-06-13	conjunto de prateleiras
DK2836460T3 (da)	2022-10-10	Fremgangsmåde til fremstilling af graphen
DK3456333T3 (da)	2020-05-18	Anvendelse af telomeraseinhibitor imetelstat til behandling af myelodysplastisk syndrom
DK2692448T3 (da)	2017-11-06	Brusehoved
DK2906219T3 (da)	2019-10-28	Orvepitant til behandling af kronisk pruritus
DK3415158T3 (da)	2021-01-11	Repeat-variable direster til targeting af nukleotider
DK2900259T3 (da)	2020-07-13	Glycosidase-regime til behandling af infektionssygdomme
DK2701707T3 (da)	2020-11-02	Fremgangsmåde til behandling af dyskinesi
FR2992364B1 (fr)	2014-07-25	Turbopompe
PL2908313T3 (pl)	2019-11-29	Adaptacyjny podział współczynnika kształt - wzmocnienie
DE112013005253A5 (de)	2015-10-08	Lebensmittelhacker
DK2828396T3 (da)	2019-05-27	Fremgangsmåde til fremstillingen af g-csf
DK2838850T3 (da)	2021-12-13	Oprensning af titantetrachlorid
FR2991392B1 (fr)	2016-01-15	Turbopompe
SI2872145T1 (sl)	2022-07-29	Taljeni benzazepini za zdravljenje Tourettovega sindroma
EP2803080A4 (en)	2015-08-12	susceptor
FR2990865B1 (fr)	2015-04-24	Autoinjecteur
EP2824698A4 (en)	2015-10-28	susceptor